LMO7-AS1

Across TCGA pan-cancer cohorts, LMO7-AS1 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LMO7-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LMO7-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types LMO7-AS1 is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.

KIRC, KIRP, and COAD are the cancer types where LMO7-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LMO7-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	−2.322	<.001	12	view →
KIRP	All	II,III,IV	−1.746	<.001	11	view →
COAD	Male	II,III,IV	+1.046	<.001	10	view →
BLCA	All	All	+0.953	<.001	9	view →
THCA	Male	All	−0.565	<.001	8	view →
STAD	Male	II,III,IV	+0.960	<.001	7	view →
HNSC	Male	III,IV	+1.118	.003	5	view →
CHOL	All	All	+1.356	<.001	3	view →
LUAD	All	IV	+2.480	.005	2	view →
READ	All	All	+0.981	.007	2	view →
LIHC	All	All	+0.191	.011	2	view →
KICH	All	All	−0.940	.010	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LMO7-AS1–KIRC

Open the KIRC breakdown →